Fosun International Ltd

Holdings History for Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)

Symbol: AMRX on Nasdaq
Investment type: Equity / Class A Common Stock, par value $0.01

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2024		-4.7%	$0	0	-1,720,855	-100%	$14.43	Q4 2024
30 Sep 2024	4.7%	-8%	$14,317,514	1,720,855	-2,934,548	-63%	$8.32	Q3 2024
30 Jun 2024	10%	-15%	$29,561,809	4,655,403	-7,658,845	-62%	$6.35	Q2 2024
31 Mar 2024	23%	-17%	$74,624,343	12,314,248	-9,207,053	-43%	$6.06	Q1 2024
31 Dec 2023	27%	0%	$130,634,297	21,521,301	0		$6.07	Q4 2023
30 Sep 2023	15%	0%	$90,819,890	21,521,301	0		$4.22	Q3 2023
30 Jun 2023	9.4%	0%	$66,716,032	21,521,301	0		$3.10	Q2 2023
31 Mar 2023	2.9%	0%	$29,914,609	21,521,301	0		$1.39	Q1 2023
31 Dec 2022	4%	0%	$42,827,417	21,521,301	0		$1.99	Q4 2022
30 Sep 2022	7.9%	0%	$43,473,000	21,521,301	0		$2.02	Q3 2022
30 Jun 2022	9.5%	0%	$68,438,000	21,521,301	0		$3.18	Q2 2022
31 Mar 2022	7.9%	0%	$89,744,000	21,521,301	0		$4.17	Q1 2022
31 Dec 2021	5.9%	0%	$103,087,000	21,521,301	0		$4.79	Q4 2021
30 Sep 2021	5.9%	0%	$114,924,000	21,521,301	0		$5.34	Q3 2021
30 Jun 2021	6.6%	0%	$110,189,000	21,521,301	0		$5.12	Q2 2021
31 Mar 2021	12%	0%	$144,839,000	21,521,301	0		$6.73	Q1 2021
31 Dec 2020	8.4%	0%	$98,351,000	21,521,301	0		$4.57	Q4 2020
30 Sep 2020	7.6%	0%	$83,503,000	21,521,301	0		$3.88	Q3 2020
30 Jun 2020	10%	0%	$102,442,000	21,521,301	0		$4.76	Q2 2020
31 Mar 2020	7.4%	0%	$74,893,000	21,521,301	0		$3.48	Q1 2020
31 Dec 2019	8.8%	0%	$103,733,000	21,521,301	0		$4.82	Q4 2019
30 Sep 2019	7.1%	+0.65%	$62,412,000	21,521,301	+1,969,300	+10%	$2.90	Q3 2019
30 Jun 2019	9.4%	0%	$140,188,000	19,552,001	0		$7.17	Q2 2019
31 Mar 2019	18%	0%	$277,052,000	19,552,001	0		$14.17	Q1 2019
31 Dec 2018	16%	0%	$264,539,000	19,552,001	0		$13.53	Q4 2018
30 Sep 2018	21%	-0.81%	$433,859,000	19,552,001	-741,350	-3.7%	$22.19	Q3 2018
30 Jun 2018	17%	+17%	$333,013,000	20,293,351	+20,293,351	NEW	$16.41	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.